View Document Preview and Link Document Date: 2015-05-19 14:14:04 Open Document File Size: 319,98 KB Share Result on Facebook
City Denver / MARLBOROUGH / / Company Dainippon Pharmaceutical Co. Ltd. / Sunovion Pharmaceuticals Inc. / Sumitomo Pharmaceuticals Co. Ltd. / Sumitomo Dainippon Pharma Co. Ltd. / / Country Japan / United States / / Currency pence / / / Event FDA Phase / M&A / / IndustryTerm owned subsidiary / pharmaceutical / pharmaceutical products / therapeutic products / healthcare burden / / MedicalCondition long-term asthma / thyrotoxicosis / COPD / chest pain / usual asthma / convulsive disorders / diarrhea / sinusitis / back pain / chronic bronchitis / asthma / cardiovascular disorders / hypertension / bronchospasm / hospitalized chronic obstructive pulmonary disease / emphysema / Chronic Obstructive Pulmonary Disease / cardiac arrhythmias / pain / correct COPD / paradoxical bronchospasm / Respiratory disease / bronchoconstriction / / MedicalTreatment alternative therapy / / Organization American Thoracic Society / U.S. Food and Drug Administration / Poster Board / / Person Krithika Rajagopalan / Vamsi Bollu / Patrick Gaffey / / / Position physician / Director / Director / Health Economics and Outcomes Research / Respiratory Group / Head of Global Health Economics and Outcomes Research / / Product Brovana / / ProvinceOrState Massachusetts / / PublishedMedium Health Economics / / URL www.fda.gov/medwatch / www.ds-pharma.com / http / SocialTag 
Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact: